Non-invasive assessment of embryo development for IVF
Official title: A Prospective, Multicenter, Observational Pilot Study to Evaluate the Combination of niPGT-A and Morphokinetics for the Non-invasive Assessment of Embryo Development
Run by Igenomix · NCT06524648 · Data updated 2026-11-12
This study is testing if using time-lapse imaging and genetic testing can help choose the best embryos for women undergoing IVF to improve their chances of pregnancy.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 20 Years to 42 Years |
| Sex | Women only |
| Enrollment | 200 (estimated) |
| Sponsor | Igenomix Industry-sponsored |
| Locations | 8 sites (Dobl and 7 other locations) |
| Status | Recruiting |
| Started | October 29, 2024 |
| Main results expected | July 2027 |
| Study ends | July 2027 |
| Registry record updated | November 6, 2026 |
| Trial ID | NCT06524648 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 20 to 42 who are planning to undergo IVF or ICSI with niPGT-A.
✕Probably not a fit
Patients with known abnormal karyotypes or certain uterine pathologies may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to improve embryo selection in in vitro fertilization (IVF) by combining two non-invasive techniques: time-lapse imaging and non-invasive preimplantation genetic testing for aneuploidies (niPGT-A). The study will evaluate morphokinetic parameters during embryo development to determine their correlation with chromosomal status. Infertile women undergoing IVF/ICSI treatment will be invited to participate, following their planned procedures without additional interventions. The goal is to enhance embryo viability evaluation and improve reproductive outcomes.
Why it matters
Potential benefit: If successful, this study could lead to better embryo selection methods, increasing the chances of successful pregnancies for patients undergoing IVF.
How similar studies have gone: While both techniques have shown promise individually, this combined approach is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Study ICF signature. * Female age between 20 and 42 years (bot included). * IVF, ICSI or IVF/ICSI performed in fresh own or donated oocytes. Note: donor sperm is allowed. * niPGT-A cases with a deferred SET (of a day 6/7 vitrified blastocyst) for any medical indication. * Embryos cultured individually in a TL system from day 0/1 to day 6/7. Exclusion Criteria: * Embryos with abnormal fertilization (different from 2PN). (Note: In case of no 2PN embryos, patients may repeat the COS cycle). * Female/couple with PGT-M and/or PGT-SR indication. * Assisted hatching and/or artificial collapse before media collection. * Known abnormal karyotype. * Pathologies or malformations affecting the uterine cavity (polyps, intramural myomas ≥ 4cm or submucosal, septum or hydrosalpinx) during the patient's participation. (Note: patients are allowed to participate if the pathology is previously operated at least 3 months before patient enrollment). * Any illness or medical condition that is unstable or which, according to medical criteria, may put at risk the patient's safety and her compliance in the study.
Where it's running
-
Kinderwunsch Institut Schenk
Dobl, Austria Recruiting -
Fertty
Barcelona, Barcelona, Spain Recruiting -
Hospital Ruber Internacional
Madrid, Madrid, Spain Recruiting -
Next Fertility Murcia
Murcia, Murcia, Spain Recruiting -
Next Fertility Sevilla
Seville, Sevilla, Spain Recruiting -
Next Fertility Valencia
Valencia, Valencia, Spain Recruiting
Show 2 more locations
-
Vida Recoletas Sevilla
Seville, Spain Recruiting -
Orchid IVF Clinic
Dubai, United Arab Emirates Recruiting
Study contacts
- Principal investigator: Luis Navarro, PhD — Igenomix
- Study coordinator: Carlos Gomez, BSc MSc
- Email: carlos.gomez@igenomix.com
- Phone: +34963905310
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-assisted embryo selection on day 5 in IVF for infertility
This trial tests whether an AI-based embryo selection tool can help pick the best embryo for transfer on day 5 in IVF/ICSI to improve pregnancy chances for people with infertility.
-
Preserving sperm quality with aging through cryopreservation
This study tests whether freezing and thawing sperm can help keep younger-like DNA and molecular traits in men as they age.
-
Unstimulated Egg Retrieval with CAPA-IVM and Euploid Embryo Transfer
This study tests whether eggs can be collected without ovarian stimulation, matured in the lab, and used to create a single euploid embryo for transfer in infertility patients.
-
Ultra-Long GnRH-a Pretreatment Before Frozen Embryo Transfer for Deep Infiltrating Endometriosis
In people under 40 with deep infiltrating endometriosis and infertility, the study tests whether two injections of a GnRH agonist before hormone support improve pregnancy outcomes in their first frozen-thawed embryo transfer.
-
Endometrial Waves and Pregnancy in FET Cycles with Hormone Therapy
This study tests whether patterns of uterine contractions during hormone-prepared frozen embryo transfer affect pregnancy outcomes.
-
Environmental and lifestyle factors linked to ART success in infertility patients
This study follows 5,000 infertile men and women to see how environmental exposures and lifestyle relate to the success of assisted reproductive technology.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.